Study of biological activity of Lys-Glu-Asp-Trp-NH2 endogenous tetrapeptide.
Khavinson. V Kh VKh; Gapparov. M M-G MM; Sharanova. N E NE; Vasilyev. A V AV; Ryzhak. G A GA
Key Findings
- The tetrapeptide was tested during normal growth (ontogeny) and in streptozotocin‑induced diabetic rats.
- Changes in metabolic parameters related to apoptosis were recorded, suggesting the peptide can influence cell‑death pathways.
- No specific dosage, route of administration, or clear functional outcomes (e.g., improved metabolism or longevity) were reported.
Practical Outcomes
- At present there is no actionable protocol for biohackers. The research is preliminary and mainly of scientific interest, offering no direct guidance on how to use the peptide for health, performance, or anti‑aging purposes.
Summary
The paper examined a naturally occurring four‑amino‑acid peptide (Lys‑Glu‑Asp‑Trp‑NH2) in developing animals and in a rat model of diabetes that mimics rapid aging. Researchers measured a bundle of metabolic markers linked to cell death (apoptosis) to see if the peptide had any protective or harmful effects. The study is very basic and does not provide dosing, safety, or clear performance benefits for humans.
Abstract
Biological effect of natural tetrapeptide Lys-Glu-Asp-Trp-NH(2)was evaluated during the ontogeny and in experimental streptozotocin-induced diabetes mellitus (a model of rapid experimental aging) by the sum of metabolic parameters characterizing apoptosis.
Study Information
pubmed
2010
2010-08-17T00:00:00.000Z
10.1007/s10517-010-0944-x
5
7